Clinical Trial Update: Denosumab for the Treatment of Adult LCH [Phase 2]

View source ↗

Summary

Clinical trial update noting completion of a Phase 2 study evaluating denosumab for adult Langerhans cell histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Hellenic Society for the Study of Bone Metabolism | Conditions: Langerhans Cell Histiocytosis | Phase 2 | Status: COMPLETED